Help
RSS
API
Feed
Maltego
Contact
Domain > dreammtrials.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2019-12-10
13.226.42.5
(
ClassC
)
2019-12-11
13.32.83.46
(
ClassC
)
2019-12-11
13.32.83.67
(
ClassC
)
2020-01-19
52.85.7.60
(
ClassC
)
2020-06-11
54.230.74.100
(
ClassC
)
2020-06-13
54.230.74.12
(
ClassC
)
2020-07-02
13.249.120.78
(
ClassC
)
2020-07-19
54.230.72.37
(
ClassC
)
2020-07-19
54.230.72.102
(
ClassC
)
2020-07-19
54.230.72.15
(
ClassC
)
2020-07-24
13.249.39.124
(
ClassC
)
2020-07-24
13.249.39.110
(
ClassC
)
2020-07-24
13.249.39.118
(
ClassC
)
2020-07-30
13.249.40.113
(
ClassC
)
2020-07-30
13.249.40.123
(
ClassC
)
2020-07-30
13.249.40.76
(
ClassC
)
2020-08-01
13.35.111.94
(
ClassC
)
2020-08-01
13.35.111.103
(
ClassC
)
2020-08-01
13.35.111.76
(
ClassC
)
2020-08-01
13.35.111.93
(
ClassC
)
2020-08-05
13.35.118.115
(
ClassC
)
2020-08-05
13.35.118.85
(
ClassC
)
2020-08-12
13.249.25.57
(
ClassC
)
2020-08-12
13.249.25.95
(
ClassC
)
2020-08-22
13.33.81.24
(
ClassC
)
2020-08-22
13.33.81.66
(
ClassC
)
2020-08-29
13.35.109.92
(
ClassC
)
2020-08-29
13.35.109.50
(
ClassC
)
2020-09-10
13.225.65.32
(
ClassC
)
2020-09-17
13.33.60.18
(
ClassC
)
2020-09-17
13.33.60.83
(
ClassC
)
2020-09-25
13.225.71.13
(
ClassC
)
2020-09-25
13.225.71.48
(
ClassC
)
2020-11-05
99.84.110.104
(
ClassC
)
2020-11-10
13.249.43.5
(
ClassC
)
2020-11-10
13.249.43.89
(
ClassC
)
2020-11-10
13.249.43.34
(
ClassC
)
2021-01-17
99.84.105.10
(
ClassC
)
2021-01-17
99.84.105.71
(
ClassC
)
2021-02-08
54.230.137.10
(
ClassC
)
2024-12-22
34.111.11.213
(
ClassC
)
2025-05-15
34.117.131.3
(
ClassC
)
Port 443
HTTP/1.1 200 OKDate: Mon, 19 Feb 2024 01:55:53 GMTServer: ApacheAccept-Ranges: bytesVary: Accept-EncodingX-Frame-Options: SAMEORIGINX-Content-Type-Options: nosniffReferrer-policy: same-originX-XSS-Pro !DOCTYPE html>html langen classtext-gray-700 font-gskslab font-medium antialiased leading-tight>head>meta charsetUTF-8>title>DREAMM Clinical Trial Program/title>meta namedescription contentInvestigating BCMA-targeted antibody-drug conjugate therapy in multiple myeloma>meta nameapplication-name contentDREAMM Clinical Trial Program>meta nameviewport contentinitial-scale1, maximum-scale1, user-scalableno, widthdevice-width>meta namemsapplication-TileColor content#d30988>meta namemsapplication-config contentbrowserconfig.fd1d0d14.xml>meta nametheme-color content#d30988>meta nameapple-mobile-web-app-capable contentyes>meta nameapple-mobile-web-app-status-bar-style contentblack>meta nameapple-mobile-web-app-title contentDREAMM Clinical Trial Program>link relpreconnect hrefhttps://www.google-analytics.com>link reldns-prefetch hrefhttps://www.google-analytics.com>link relpreconnect hrefhttps://tags.tiqcdn.com>link reldns-prefetch hrefhttps://tags.tiqcdn.com>link relapple-touch-icon sizes180x180 hrefapple-touch-icon.f4719461.png>link relicon typeimage/png sizes32x32 hreffavicon-32x32.7745c2f4.png>link relicon typeimage/png sizes16x16 hreffavicon-16x16.0403144e.png>link relmanifest hrefsite.webmanifest>link relshortcut icon hreffavicon.a0419f45.ico>link relstylesheet hrefcss.09173b02.css>/head>body classbg-gray-50> script>!function(e,t,a,n){e//tags.tiqcdn.com/utag/gsk/profile-rx-gb/prod/utag.js,ascript,(n(tdocument).createElement(a)).srce,n.typetext/java+a,n.async!0,(et.getElementsByTagName(a)0).parentNode.insertBefore(n,e)}();/script> div classbg-gray-100 shadow-masthead> div classflex items-center bg-white pl-5 pr-3 md:px-5 lg:px-10 py-5> a href./ classz-40> img srcdreamm-logo.d59fe7b2.png width147 height50 altDREAMM classmt-2 mb-0 md:mt-1 md:mb-1> /a> div classflex-1 inline-flex justify-end pt-4 flex md:hidden> button classhamburger hamburger--slider focus:outline-none clean-select z-40 typebutton aria-labelMenu> span classhamburger-box> span classhamburger-inner>/span> /span> /button> div classmobilemenu absolute i
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]